Both chlamydia and gonorrhea can cause asymptomatic infections missed during routine visits.
The study focused on patients who take PrEP, as this population is at higher risk for other STIs.
The organization hopes the database will help improve understanding of STI prevalence in low- and middle-income countries.
Because chlamydia often produces no symptoms, screening for sexually active young women can help prevent pelvic inflammatory disease.
The findings underscore the need for more education as some sexually transmitted infections increase, the authors say.
New surveillance data show cases of gonorrhea, syphilis, and congenital syphilis have reached their highest levels in over a decade.
An observational study in California finds doxycycline post-exposure prophylaxis remains very effective against chlamydia and syphilis, but is not effective against gonorrhea.
The European health agency says decisions on doxycycline post-exposure prophylaxis use should be made at the individual level, following clinical judgement and national guidelines.
Data on more than 1.4 millions incarcerated individuals in 43 countries shows STI rates are particularly high in adolescents and women.
The report is in response to a continent-wide surge in STIs since 2014.